Autism risk study for children born to mothers with HIV in Kenya
Part of Mental health clinical trials.
This study looks at how being born to a mother with HIV might affect a child's brain development and behavior. It will check for early signs of autism in children ages 2 to 6 years old.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 2 and 6 years old
- Your child is already part of the Tabiri study in Kenya
- Your child is HIV-exposed but uninfected, or HIV-unexposed and uninfected
- You speak Kiswahili or English
- Your child can take part even if they develop HIV later
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses eye tracking technology to help detect early signs of autism in young children during regular health checkups. It may help identify children who could benefit from early support.
This study tests whether a tablet/computer app can reliably spot early autism signs in toddlers. If it works well, it could help families and clinicians screen sooner and more accurately.
This study is testing ways to support caregivers of young children who may have autism. It aims to find helpful programs that fit your family's needs.
This study looks at how a mother's health and environment during pregnancy may relate to autism in her child. It uses samples collected during pregnancy from first-time mothers who were part of the nuMoM2b study.
This study tests whether a simple eye-tracking technique can help identify autism in young children who were born before 37 weeks. It aims to make autism testing easier and earlier, which could lead to better support.
This trial checks how 8- to 10-month-old babies visually engage with people, which may help screen for autism risk earlier. It may help by improving early identification, especially for families who want screening done in a research setting.
Hear when a new Autism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.